| Breakdown | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 119.38B | 115.44B | 113.50B | 109.05B | 106.62B |
| Gross Profit | 33.71B | 32.43B | 33.30B | 32.10B | 30.59B |
| EBITDA | 16.45B | 15.60B | 15.17B | 14.70B | 13.92B |
| Net Income | 9.09B | 8.97B | 7.64B | 7.28B | 8.31B |
Balance Sheet | |||||
| Total Assets | 189.76B | 179.94B | 166.13B | 163.38B | 163.63B |
| Cash, Cash Equivalents and Short-Term Investments | 31.32B | 33.45B | 36.35B | 37.50B | 41.16B |
| Total Debt | 14.74B | 13.59B | 14.75B | 19.44B | 21.32B |
| Total Liabilities | 57.60B | 56.20B | 51.99B | 55.65B | 59.01B |
| Stockholders Equity | 131.65B | 122.80B | 113.15B | 106.63B | 102.94B |
Cash Flow | |||||
| Free Cash Flow | 5.13B | 5.04B | 5.88B | 5.14B | 9.18B |
| Operating Cash Flow | 12.14B | 10.16B | 8.99B | 9.45B | 12.40B |
| Investing Cash Flow | -9.26B | -7.86B | 990.00M | -6.88B | -2.09B |
| Financing Cash Flow | -5.07B | -4.21B | -9.77B | -9.50B | -1.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥116.62B | 15.30 | ― | 1.79% | 10.76% | 54.82% | |
78 Outperform | ¥170.61B | 9.78 | 10.24% | 2.43% | 6.08% | 8.55% | |
74 Outperform | ¥115.30B | 13.53 | ― | 2.66% | 7.56% | -17.12% | |
72 Outperform | ¥13.33B | 4.54 | ― | 4.80% | 4.49% | 26.84% | |
66 Neutral | ¥114.54B | 17.53 | 2.80% | 3.38% | >-0.01% | -49.83% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | ¥3.81B | 14.35 | ― | 2.63% | -3.01% | -65.96% |